Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/26/2012CA2690490C Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
06/26/2012CA2536185C Drug delivery system by administrating fine particles to sub-tenon
06/26/2012CA2535123C Bioadhesive gel based on hydroxyethylcellulose
06/26/2012CA2534056C Calcium carbonate granulation
06/26/2012CA2458126C Composition for stabilizing hyaluronic acid
06/26/2012CA2425602C Methods of high-throughput screening for internalizing antibodies
06/26/2012CA2421133C Devices, systems and methods for patient infusion
06/26/2012CA2420584C Convection-enhanced drug delivery device and method of use
06/26/2012CA2395678C Antimicrobial compositions and methods of use
06/26/2012CA2371689C Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatment
06/26/2012CA2328614C Matrices for drug delivery and methods for making and using the same
06/26/2012CA2237316C Complex cationic lipids
06/21/2012WO2012083138A2 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
06/21/2012WO2012083026A1 Branched polyol polyesters, blends and pharmaceutical formulations comprising same
06/21/2012WO2012083017A2 Controlled release oral dosage forms of poorly soluble drugs and uses thereof
06/21/2012WO2012082658A2 Antimicrobial ultrasound transmission gel or couplant
06/21/2012WO2012082631A1 Delivery of functional compounds
06/21/2012WO2012082209A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration
06/21/2012WO2012082165A1 Irradiated biodegradable polymer microparticles
06/21/2012WO2012082083A1 Pharmaceutical formulation containing tetrahydrolipstatin as an active ingredient
06/21/2012WO2012082065A1 New particle stabilized emulsions and foams
06/21/2012WO2012081905A2 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
06/21/2012WO2012081676A1 Oxidation reaction product of hop extract, process for production thereof, and use thereof
06/21/2012WO2012081673A1 Ophthalmic composition for contact lens
06/21/2012WO2012080987A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012WO2012080986A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012WO2012080918A2 Wear resistant antimicrobial compositions and methods of use
06/21/2012WO2012080915A1 Sterile injectable aqueous formulation used in ophthalmology
06/21/2012WO2012080882A1 Solid compositions containing nonsteroidal anti-inflammatory drugs, the processes for their preparation and their use.
06/21/2012WO2012080833A2 Controlled release dosage forms
06/21/2012WO2012080718A1 Novel pharmaceutical formulation comprising nsaid and cyclodextrin
06/21/2012WO2012080471A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/21/2012WO2012080408A1 Pharmaceutical composition for oral administration intended to prevent misuse
06/21/2012WO2012080399A1 Zolpidem-based orodispersible pharmaceutical tablet
06/21/2012WO2012080365A1 Transdermal therapeutic system for administering an active substance
06/21/2012WO2012080329A1 Formulations of n-(3,5-dichloropyridin-4-yl)-[1-(4-fluorobenzyl)-7-azaindol-3-yl)]glyoxylic acid amide
06/21/2012WO2012080216A1 Orally disintegrating tablet having a taste masking effect
06/21/2012WO2012080184A2 Liquid pharmaceutical compositions which can be administered orally and contain 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide
06/21/2012WO2012080176A2 Pharmaceutical compositions
06/21/2012WO2012079721A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
06/21/2012WO2012079679A1 Dry granulated cell culture media
06/21/2012WO2012079671A2 Method for producing δ-mannitol which can be directly tableted
06/21/2012WO2012079419A1 Pharmaceutical composition for treating macular degeneration
06/21/2012WO2012079311A1 A sea cucumber compound product, preparation method and preparation forms thereof
06/21/2012WO2012079232A1 Compounds used for treating cancer and the use thereof
06/21/2012WO2012061445A3 Rna-directed packaging of enzymes within protein particles
06/21/2012WO2012056471A3 Preparing dexibuprofen ready-to-compress granules
06/21/2012WO2012054376A3 Metal ion nanoclusters
06/21/2012WO2012052178A3 Improved pharmaceutical starter pellets
06/21/2012WO2012042023A3 Cyclosporine emulsion
06/21/2012WO2012041995A4 Process for preparing a chemical structure having a phase partition, capable of generating a specific fluorescence spectrum and uses thereof
06/21/2012WO2012040710A3 Stabilized nanobubbles for diagnostic and therapeutic applications
06/21/2012WO2012031205A3 Lipid-polymer hybrid particles
06/21/2012WO2012031124A3 Drug formulations using water soluble antioxidants
06/21/2012WO2012027514A3 Compositions and methods for cardiac therapy
06/21/2012WO2012021512A3 Erythrocyte-binding therapeutics
06/21/2012WO2011163600A3 Tacrolimus compositions for aerosol administration
06/21/2012WO2011161223A3 Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
06/21/2012WO2011161123A3 Multilayer pharmaceutical tablet comprising telmisartan and a diuretic
06/21/2012WO2011135314A3 Pharmaceutical powder compositions
06/21/2012US20120158114 Cochlear implant drug delivery device
06/21/2012US20120157939 Compositions comprising lilium siberia extracts and uses thereof
06/21/2012US20120157937 Transdermal therapeutic system provided with improved long-term carrying comfort
06/21/2012US20120157685 Intermediate release nicotinic acid compositions for treating hyperlipidemia which exhibit an in vivo stair-stepped absorption curve
06/21/2012US20120157550 Drug carriers comprising amphilphilic block copolymers
06/21/2012US20120157503 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
06/21/2012US20120157499 Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
06/21/2012US20120157423 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156304 Branched polyol polyesters, blends, and pharmaceutical formulations comprising same
06/21/2012US20120156302 Biodegradable particle and method for producing the same
06/21/2012US20120156301 Methods and Compositions for Treating and Preventing Symptoms of Hormonal Variations
06/21/2012US20120156300 Microbubbles and methods for oxygen delivery
06/21/2012US20120156299 Compositions comprising lilium martagon extracts and uses thereof
06/21/2012US20120156298 Compositions comprising lilium siberia extracts and uses thereof
06/21/2012US20120156297 Compositions comprising lilium candidum extracts and uses thereof
06/21/2012US20120156296 Antioxidants in fish oil powder and tablets
06/21/2012US20120156295 Antibiotic compounds
06/21/2012US20120156294 Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
06/21/2012US20120156293 Antacid and laxative tablet
06/21/2012US20120156292 Stable compositions of famotidine and ibuprofen
06/21/2012US20120156291 Stable compositions of famotidine and ibuprofen
06/21/2012US20120156290 Process for preparing oxymorphone, naltrexone, and buprenorphine
06/21/2012US20120156289 Biodegradable Osmotic Pump Implant For Drug Delivery
06/21/2012US20120156288 Microcapsules containing salts for food products
06/21/2012US20120156287 Use of Vitelline Protein B as a Microencapsulating Additive
06/21/2012US20120156286 Compositions and methods for increased delivery of coenzyme q10
06/21/2012US20120156285 Methods of treating hypertriglyceridemia
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156283 Methods and Compositions for Wound Treatment
06/21/2012US20120156282 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
06/21/2012US20120156281 Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein
06/21/2012US20120156280 Myeloid derived suppressor cell inhibiting agents
06/21/2012US20120156279 High penetration prodrug compositions of peptides and peptide-related compounds
06/21/2012US20120156278 Systems and methods for preparing autologous fibrin glue
06/21/2012US20120156277 Abuse resistant drugs, method of use and method of making
06/21/2012US20120156276 Connective tissue stimulating peptides
06/21/2012US20120156272 Composition for cosmetic, pharmaceutical or dietary applications
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156264 Injectable depot formulation comprising crystals of iloperidone
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 2991